Number of the records: 1
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
- 1.Průková, D., Anděra, L., Nahácka, Z., Karolová, J., Svaton, M., Klánová, M., Havránek, O., Soukup, J., Svobodová, K., Zemanová, Z., Tušková, D., Pokorná, E., Helman, K., Forsterova, K., Pacheco-Blanco, M., Vočková, P., Berková, A., Froňková, E., Trněný, M., Klener, P. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 2019, 25(14), 4455-4465. ISSN 1078-0432. E-ISSN 1557-3265. Available: doi: 10.1158/1078-0432.CCR-18-3275.
Number of the records: 1